Effect of smoking on dose requirements for vecuronium

British Journal of Anaesthesia

Volumn 76, Issue 1, 1996, Pages 154-155

  Teiria H ^a   Rautoma, P ^a   Yli Hankala, A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Complications, smokers; Neuromuscular block, vecuronium

Indexed keywords

ALFENTANIL; NITROUS OXIDE; PROPOFOL; VECURONIUM;

ADULT; ARTICLE; CIGARETTE SMOKING; DRUG POTENCY; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; PHARMACODYNAMICS; PRIORITY JOURNAL; SMOKING;

EID: 0030034872     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.1.154     Document Type: Article

References (6)

1. Dawson GW, Vestal RE. Smoking and drug metabolism. Pharmacology and Therapeutics 1982; 15: 207-221.
2. Kroeker KA, Beattie WS, Yang H. Neuromuscular blockade in the setting of chronic nicotine exposure. Anesthesiology 1994; 81: A1120.
3. Meretoja OA, Wirtavuori K. Two-dose technique to create an individual dose-response curve for atracurium. Anesthesiology 1989; 70: 732-736.
4. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P, eds. The Pharmacological Basis of Therapeutics, vol. 1. New York: McGraw Hill Inc., 1992; 166-186.
5. Russell MAH, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. British Medical Journal 1980; 280: 972-975.
6. Gibson FM, Mirakhur RK, Clarke RSJ, Lavery GG. Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. British Journal of Anaesthesia 1985; 57: 1060-1062.